2 news items
Appointment of Stephen M. Deitsch as new Chief Financial Officer
FNA
4 Apr 24
." Stephen Deitsch, Chief Financial Officer, said, "It is an honour to join OrganOx, a truly innovative medical technology
Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024
FNA
4 Apr 24
focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative
- Prev
- 1
- Next